Study of ngolimod therapy on cerebral grey matter (GM) atrophy over two years in patients with relapsing forms of multiple sclerosis (MS)
Latest Information Update: 06 Sep 2018
At a glance
- Drugs Fingolimod (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- 06 Sep 2018 New trial record